Fortis Healthcare (FORTIS) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
8 Jul, 2026Executive summary
Consolidated Q3 FY26 revenues reached INR 2,265 crore, up 17.5% year-over-year, with both hospital and diagnostics segments showing strong growth despite seasonal festival impacts.
Q3 FY26 consolidated PAT (excluding exceptional items) was INR 243 crore, up 15.6% year-over-year; PAT declined to INR 197 crore due to a one-off INR 55 crore labor code expense, partially offset by a reversal of impairment in an associate.
Acquisition of People Tree Hospital in Bengaluru for INR 430 crore and launch of Adayu, a 36-bed mental health facility in Gurugram, expanded the network and service offerings.
Board approved unaudited financial results for the quarter and nine months ended December 31, 2025, with no material misstatements per statutory auditor.
Financial highlights
Nine-month FY26 consolidated revenue was INR 6,763 crore, up 17.1% year-over-year; Q3 operating EBITDA was INR 505 crore (22.3% margin), up 34.8% year-over-year.
Net debt stood at INR 2,547 crore, with net debt/EBITDA at 1.24x as of December 31, 2025.
Hospital ARPOB increased 4.5% year-over-year to INR 2.56 crore per annum, with occupancy stable at 67%.
Digital channels contributed nearly 30% of hospital revenues in Q3, with digital revenue up 19% year-over-year.
EBITDA for the quarter was INR 51,394 lacs (consolidated) and INR 11,498 lacs (standalone).
Outlook and guidance
Management expects continued growth in revenue and margins, supported by brownfield expansions, operational improvements, and ongoing bed expansion projects in Manesar, Noida, and FMRI.
ARPOB is expected to grow 4-5% annually over the next two years, with half from price and half from case mix.
Brownfield expansion of 400+ beds targeted for next year, mainly at FMRI, with most CapEx already incurred.
M&A pipeline focused on strengthening existing clusters, with Hyderabad now included as a potential cluster.
The company is focused on operational consolidation and brand transitions, with recent acquisitions and restructuring to strengthen business.
Latest events from Fortis Healthcare
- Q1 FY27 saw 17.5% revenue growth, robust margins, and ongoing legal and regulatory matters.FORTIS
Q1 26/277 Aug 2026 - Q1 FY25 saw strong revenue and profit growth, margin expansion, and dividend approval.FORTIS
Q1 24/259 Jul 2026 - Q2 FY26 delivered 17.3% revenue growth, 120.7% PAT rise, and strong expansion momentum.FORTIS
Q2 25/269 Jul 2026 - Strong revenue, EBITDA, and PAT growth, with major expansion and acquisition moves.FORTIS
Q2 24/258 Jul 2026 - Strong FY26 growth, margin expansion, acquisitions, and compliance amid ongoing legal matters.FORTIS
Q4 25/2618 Jun 2026 - Strong revenue and profit growth, margin expansion, and Agilus acquisition mark the quarter.FORTIS
Q3 24/259 Dec 2025 - Strong revenue and profit growth, margin expansion, and key acquisitions completed.FORTIS
Q1 25/2623 Nov 2025 - FY25 saw strong revenue and profit growth, major acquisitions, and a positive outlook.FORTIS
Q4 24/2520 Nov 2025